Nanomedicine & Bioconjugation Symposium 2026
Ardena’s first nanomedicine symposium brings together leading scientists, clinicians, and industry experts to discuss the latest advances in nanomedicine. Over two days, you will hear from and engage directly with – international key opinion leaders, industry innovators, and Ardena’s own nanomedicine experts
WHERE
Location
Oss, The Netherlands
WHEN
Date
15–16 September 2026
WHO
Audience
C-level executives, CMC experts, and senior scientists from biotech, pharma, and academia
Speakers
Dr. Glenn Meyer
CMC, Product Development, Peptinovo Biopharma
Prof. Dr. Dr. Twan Lammers
Department of Nanomedicine and Theranostics Institute for Experimental Molecular Imaging RWTH Aachen University Clinic
María J. Alonso, Ph.D.
Professor of Pharmaceutical Technology at the University of Santiago de Compostela (USC), Spain
Scientific focus areas
Nanomedicines in clinical development
Bioconjugation
mRNA / LNP formulation strategies
Analytical characterisation of complex modalities
What's included for participants
Selected participants receive
Apply via form below-
Full two-day symposium access
-
Certificate of attendance
-
Networking dinner and welcome reception
Apply to Attend
Places are limited and participants are selected based on scientific background and relevance to the symposium topics. Once confirmed, hotel accommodation is taken care of — just show up ready to talk science.
Selective attendance. Submitting this form is an application, not a confirmed registration. Our team reviews each submission and will contact you within a few working days to confirm your place.
